Search Results 911-920 of 2437 for 2024embarking
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label- ...
Latest stories · Infectious Diseases A-Z: Top public health threats featured image · Post-op complication measurements differ, Mayo Clinic study finds featured ...
About this study. The purpose of this study is to prospectively evaluate the prognostic role of ITC versus negative nodes in patients with low-risk ...
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect ...
ROCHESTER, Minn. — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a ...
Mayo Clinic researchers made significant strides in 2025 toward predicting, preventing and treating some of the world's most serious and complex diseases.
Mayo Clinic researcher Fergus Couch, Ph.D., has spent his career studying inherited breast cancer and cancer genetics. Early on, he saw that many families lived ...
Taking Mayo Clinic research beyond the lab and into space featured image · Role identifier badges can assist patients, reduce perceptions of bias in health care ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.